Neonatal hyperbilirubinemia: Background and recent literature updates on the diagnosis and treatment

H Nawaz1, M Aslam1, T Rehman2

  • 11Department of Biochemistry, Bahauddin Zakariya University, 60800, Multan, Pakistan.

Insights

Neonatal hyperbilirubinemia (jaundice) research is advancing, with new treatments emerging. This review covers recent advancements in understanding and managing jaundice in newborns, though more research is needed.

Area of Science:

  • Medical Research
  • Neonatology
  • Biochemistry

Background:

  • Hyperbilirubinemia (jaundice) is a significant clinical concern due to its varied etiologies and potential toxicity, particularly in neonates.
  • Past research focused on bilirubin metabolism and disorders, primarily in the late 20th century.
  • Recent technological and research progress has opened new avenues for investigating neonatal hyperbilirubinemia.

Purpose of the Study:

  • To provide an overview of hyperbilirubinemia and jaundice.
  • To highlight recent advancements in the treatment of neonatal hyperbilirubinemia.
  • To discuss modifications of existing methods and novel treatment findings.

Main Methods:

  • Literature review of recent advancements in neonatal hyperbilirubinemia research.
  • Analysis of modified and newly developed treatment methods.
  • Synthesis of current knowledge on hyperbilirubinemia and jaundice.

Main Results:

  • Recent research has expanded understanding of hyperbilirubinemia causes and treatments.
  • Modifications to established treatment protocols have been reported.
  • Novel treatment approaches for neonatal jaundice are emerging.

Conclusions:

  • Significant progress has been made in understanding and treating neonatal hyperbilirubinemia.
  • While current literature is extensive, further research is essential.
  • Continued investigation is crucial for improving outcomes for infants with jaundice.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
421
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.3K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.5K